Article
CRISPR-Cas9 immune-evasive hESCs are rejected following transplantation into immunocompetent mice
28 May 2024
Abstract excerpt
Although current stem cell therapies exhibit promising potential, the extended process of employing autologous cells and the necessity for donor–host matching to avert the rejection of transplanted cells significantly limit the widespread applicability of these treatments. It would be highly advantageous to generate a pluripotent universal donor stem cell line that is immune-evasive and, therefore, not restricted...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
